Braveheart is one of five biotechnology firms that made plans to price an IPO this week, bringing in total what could ...
EatingWell on MSN
The FDA just approved a new cholesterol pill—here’s what cardiologists want you to know
Not to be confused with statins, this new pill is the first of its kind.
The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart ...
The results of a recent clinical trial have shown that tirzepatide, a drug used to treat obesity and diabetes, can reduce the risk of death or worsening heart failure for patients who have obesity and ...
As a preventative cardiologist at Vital Heart & Vein, Dr. Patrick Kee, MD, Ph.D has too often seen people discover that they have high blood pressure only after a crisis, like a heart attack, happens ...
It can impact how your medication works.
Health care is full of passionate people who choose their field because of motivation to help the sick and injured. That passion can lead to big, audacious goals, like ‘reduce obesity,’ or ‘improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results